Hørsholm, Denmark (PRWEB) May 28, 2014
Visiopharm is pleased to announce the appointment of Benjamin Freiberg, PhD as Director of Sales for the Americas. In his new role Ben will be responsible for sales growth and the expansion of Visiopharm sales team through both direct and indirect channels. Ben will also have an active role in Visiopharm’s sales strategy and growth plan for North America.
Ben Freiberg earned his doctorate in immunology at the University of Colorado Health Sciences Center, focusing on T cell biology. Over the past 15 years, Dr. Freiberg joined Intelligent Imaging Innovations (3i) as their lead sales, marketing and strategic business partner. He then moved on to Lumencor and built their brand of light engines on a global basis and managed the international team of Lumencor sales staff as well as resellers. Sales growth for Visiopharm’s Americas market is well served by Ben’s comprehensive knowledge of the highest performance methods for quantitative image processing and analysis.
Amanda Lowe, Director of Business Development, stated, “Ben is an excellent addition to our leadership team. Visiopharm has seen strong, consistent business growth throughout North America over the past several years. Dr. Freiberg’s successful track record of direct sales support, reseller support, business acumen and strong product development will build on our established success in the America’s market. Ben’s experience in software and hardware development for biology, oncology, immunology and cell biology will benefit Visiopharm customers and markets from a deep appreciation of biology and experimental design.”
Ben Freiberg stated, “I’m looking forward to joining the stellar Visiopharm team and providing sales leadership and management throughout the organization. I believe that my combination of skills in business, biology, sales and leadership will augment Visiopharm’s success and help drive sales to the next level. I am honored to be working for such a forward thinking company whose greatest successes lay in the near future.”
Ben will be based out of Visiopharm’s North America office in Broomfield, Colorado.
Over the past 13 years, Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for healthcare, life science, and biopharmaceutical organizations all over the world. Our software is featured in over 650 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras. Visiopharm has grown into an international business with over 450 customers in more than 30 countries. Our growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Visiopharm is headquartered in the Medicon Valley of Denmark and has a North America office in Broomfield, Colorado.